UBIO

Fund Description
This Ultra ProShares ETF seeks a return that is 3x the return of an index or other benchmark (target) for a single day, as measured from one NAV calculation to the next. Due to the compounding of daily returns, ProShares returns over periods other than one day will likely differ in amount and possibly direction from the target return for the same period. These effects may be more pronounced in funds with larger or inverse multiples and in funds with volatile benchmarks. The NASDAQ Biotechnology Index is a modified capitalization-weighted index that includes securities of The NASDAQ Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The NASDAQ OMX Group Inc., including minimum market capitalization and liquidity requirements.
Fund Profile
Fund Name ProShares UltraPro NASDAQ Biotechnology
Fund Exchange Ticker UBIO
Fund Sponsor ProShares
Fund ISIN US74347B4749
Net Expense Ratio 0.95 %
Fund Inception Date 22 June 2015
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific Leveraged / Inverse
Asset Class Equities (Stocks)
Index Linked Passive
Index Name NASDAQ Biotechnology Index
Index Provider Nasdaq
Currency Hedged No
Inverse / Leveraged Leveraged (3x)
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 18 January 2019
Asset Under Management 35.23 Million (USD)
1 Month Total Return 37.45 %
Year To Date Return 47.00 %
1 Year Total Return -22.28 %
3 Year Annualized Total Return -1.60 %
NAV 29.36
Share Outstanding 1,199,920
Top 10 Holdings (18 January 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
PARATEK PHARMACEUTICALS INC PRTK EQUI
RETROPHIN INC RTRX EQUI
UNUM THERAPEUTICS INC UMRX EQUI
CORIUM INTERNATIONAL INC CORI EQUI
Net Other Assets / Cash CASH
SURFACE ONCOLOGY INC SURF EQUI
PROTEOSTASIS THERAPEUTICS IN PTI EQUI
EYEPOINT PHARMACEUTICALS INC EYPT EQUI
ADURO BIOTECH INC ADRO EQUI
AEGLEA BIOTHERAPEUTICS INC AGLE EQUI